It demonstrates that Indian scientists, researchers and engineers are second to none and that Indian biopharma companies can develop advanced therapies that conform to best-in-class global quality standards. Over time, other pharma and biotech companies could emulate our success if like Biocon, ...
Read more: Indian cos now in race to create generic versions of biologics with larger global opportunity: Kiran ...